CD40L (Ruplizumab Biosimilar) Antibodies
(CD40L (Ruplizumab Biosimilar))
The protein encoded by this gene is expressed on the surface of T cells. It regulates B cell function by engaging CD40 on the B cell surface. A defect in this gene results in an inability to undergo immunoglobulin class switch and is associated with hyper-IgM syndrome. [provided by RefSeq, Jul 2008].
antibodies-online.com stands for high-quality research products. Search, find and order tools with extensive validation data, images, references. Our scientific customer service is always at your disposal if you have any questions about the selection or application of our products.
Recommended CD40L (Ruplizumab Biosimilar) Antibodies
Product
Reactivity
Application
Validations
Cat. No.
Quantity
Datasheet
Reactivity
Human
Application
FACS, ELISA
Validations
- (1)
Cat. No.
ABIN7093061
Quantity
100 μg
Datasheet
Datasheet
Reactivity
Human
Application
FACS, WB, BR
Validations
- (1)
Cat. No.
ABIN5668047
Quantity
200 μg
Datasheet
Datasheet
Reactivity
Human
Application
FACS, WB, BR
Validations
- (1)
Cat. No.
ABIN5668046
Quantity
200 μg
Datasheet
Datasheet
Synonyms and alternative names related to CD40L (Ruplizumab Biosimilar)
CD40 ligand (CD40LG), CD40L, CD154, gp39, hCD40L, HIGM1, IGM, IMD3, T-BAM, TNFSF5, TRAPProtein level used designations for CD40L (Ruplizumab Biosimilar)
- CD40 antigen ligand
- CD40-L
- T-B cell-activating molecule
- T-cell antigen Gp39
- TNF-related activation protein
- tumor necrosis factor (ligand) superfamily member 5
- CD40 ligand (TNF superfamily, member 5, hyper-IgM syndrome)
- tumor necrosis factor (ligand) superfamily, member 5
- tumor necrosis factor ligand superfamily member 5
You are here:
